SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS)
$81.08 -2.23 (-2.6767%)
Analysed SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) News Sources
AG Drummond announces $469 million settlement with Sandoz over drug pricing scheme
05-08-2026
kfor.com
Sandoz Inc. agrees to $469M settlement in generic drug price-fixing case, Tong says
06-08-2026
ctinsider.com
Sandoz targets industry patent void with $322m Henlius deal
17-08-2026
pharmaceutical-technology.com
AstraZeneca scores in lung cancer; Sandoz inks a China deal
18-08-2026
biopharmadive.com
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
27-08-2026
yahoo.com
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
31-08-2026
yahoo.com
“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy
09-09-2026
pharmaceutical-technology.com
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
05-06-2026
yahoo.com
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
17-08-2026
yahoo.com
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
08-09-2026
yahoo.com
What is the current price of SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS)?
The current price of SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) is $81.08.
SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) since the previous trading day is $-2.23.
SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) since the previous trading day is -2.6767%.
What is the most recent average sentiment score for SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS)?
The most recent average sentiment score for SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) is 69 out of 100.
What is the most recent average sentiment for SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS)?
The most recent sentiment for SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS) is .
SEC-8K** Filing Available For SANDOZ GROUP AG-ADR (SDZNY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.